Approval Year
| Substance Class |
Mixture
Created
by
admin
on
Edited
Fri Dec 15 16:28:36 UTC 2023
by
admin
on
Fri Dec 15 16:28:36 UTC 2023
|
| Record UNII |
7DP3NTV15T
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C2311
Created by
admin on Fri Dec 15 16:28:36 UTC 2023 , Edited by admin on Fri Dec 15 16:28:36 UTC 2023
|
||
|
FDA ORPHAN DRUG |
76193
Created by
admin on Fri Dec 15 16:28:36 UTC 2023 , Edited by admin on Fri Dec 15 16:28:36 UTC 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
m2589
Created by
admin on Fri Dec 15 16:28:36 UTC 2023 , Edited by admin on Fri Dec 15 16:28:36 UTC 2023
|
PRIMARY | Merck Index | ||
|
C312
Created by
admin on Fri Dec 15 16:28:36 UTC 2023 , Edited by admin on Fri Dec 15 16:28:36 UTC 2023
|
PRIMARY | |||
|
7DP3NTV15T
Created by
admin on Fri Dec 15 16:28:36 UTC 2023 , Edited by admin on Fri Dec 15 16:28:36 UTC 2023
|
PRIMARY | |||
|
DTXSID2047800
Created by
admin on Fri Dec 15 16:28:36 UTC 2023 , Edited by admin on Fri Dec 15 16:28:36 UTC 2023
|
PRIMARY | |||
|
7DP3NTV15T
Created by
admin on Fri Dec 15 16:28:36 UTC 2023 , Edited by admin on Fri Dec 15 16:28:36 UTC 2023
|
PRIMARY | |||
|
1076308
Created by
admin on Fri Dec 15 16:28:36 UTC 2023 , Edited by admin on Fri Dec 15 16:28:36 UTC 2023
|
PRIMARY | |||
|
1621
Created by
admin on Fri Dec 15 16:28:36 UTC 2023 , Edited by admin on Fri Dec 15 16:28:36 UTC 2023
|
PRIMARY | RxNorm | ||
|
232-925-2
Created by
admin on Fri Dec 15 16:28:36 UTC 2023 , Edited by admin on Fri Dec 15 16:28:36 UTC 2023
|
PRIMARY | |||
|
DBSALT000196
Created by
admin on Fri Dec 15 16:28:36 UTC 2023 , Edited by admin on Fri Dec 15 16:28:36 UTC 2023
|
PRIMARY | |||
|
SUB00844MIG
Created by
admin on Fri Dec 15 16:28:36 UTC 2023 , Edited by admin on Fri Dec 15 16:28:36 UTC 2023
|
PRIMARY | |||
|
9041-93-4
Created by
admin on Fri Dec 15 16:28:36 UTC 2023 , Edited by admin on Fri Dec 15 16:28:36 UTC 2023
|
PRIMARY | |||
|
BLEOMYCIN SULFATE
Created by
admin on Fri Dec 15 16:28:36 UTC 2023 , Edited by admin on Fri Dec 15 16:28:36 UTC 2023
|
PRIMARY | Description: A white or cream-coloured, amorphous powder. Solubility: Very soluble in water. Category: Cytotoxic drug. Storage: Bleomycin sulfate should be kept in a tightly closed container. Labelling: The designation sterile Bleomycin sulfate indicates that the substance complies with the additional requirements forsterile Bleomycin sulfate and may be used for parenteral administration or for other sterile applications. CAUTION: Bleomycinsulfate must be handled with care, avoiding contact with the skin and inhalation of airborne particles. Definition: Bleomycin sulfate is the sulfate salt of a mixture of substances produced by the growth of Streptomyces verticillus. | ||
|
CHEMBL3039590
Created by
admin on Fri Dec 15 16:28:36 UTC 2023 , Edited by admin on Fri Dec 15 16:28:36 UTC 2023
|
PRIMARY |
All of the following components must be present:
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
http://apps.who.int/phint/pdf/b/Jb.6.1.61.pdf
|
